# Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

> **NCT01448668** · — · UNKNOWN · sponsor: **IFAG AG** · enrollment: 220 (actual)

## Conditions studied

- Pancreas Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01448668
- **Lead sponsor:** IFAG AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448668, "Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01448668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*